NAUT vs CDNA vs SEER vs QBTS vs ILMN

For growth investors, D-Wave Quantum Inc.

(QBTS) is the stronger pick with 178. 5% revenue growth year-over-year, versus -8. 1% for Seer, Inc. (SEER). Illumina, Inc. (ILMN) offers the better valuation at 25. 5x trailing P/E (26. 8x forward), making it the more compelling value choice. Analysts rate Nautilus Biotechnology, Inc. (NAUT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, CareDx, Inc is actually cheaper at 22.

8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, D-Wave Quantum Inc.

(QBTS) delivered a total return of +122. 2%, compared to -95. 1% for Seer, Inc. (SEER). Over 10 years, the gap is even starker: CDNA returned +385. 1% versus SEER's -96. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Seer, Inc.

(SEER) is the lower-risk stock at 0. 84β versus D-Wave Quantum Inc. 's 3. 48β — meaning QBTS is approximately 314% more volatile than SEER relative to the S&P 500. On balance sheet safety, D-Wave Quantum Inc. (QBTS) carries a lower debt/equity ratio of 1% versus 94% for Illumina, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), D-Wave Quantum Inc.

(QBTS) is pulling ahead at 178. 5% versus -8. 1% for Seer, Inc. (SEER). On earnings-per-share growth, the picture is similar: Illumina, Inc. grew EPS 170. 9% year-over-year, compared to -143. 0% for CareDx, Inc. Over a 3-year CAGR, QBTS leads at 50. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Illumina, Inc.

(ILMN) is the more profitable company, earning 19. 6% net margin versus -1444. 1% for D-Wave Quantum Inc. — meaning it keeps 19. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ILMN leads at 19. 9% versus -717. 7% for SEER. At the gross margin level — before operating expenses — QBTS leads at 82. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, CareDx, Inc (CDNA) trades at 22.

8x forward P/E versus 26. 8x for Illumina, Inc. — 3. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for QBTS: 76. 8% to $38. 89.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Seer, Inc.

(SEER) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 84)). D-Wave Quantum Inc. (QBTS) carries a higher beta of 3. 48 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SEER: -96. 7%, QBTS: +116. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NAUT (Healthcare) and CDNA (Healthcare) and SEER (Healthcare) and QBTS (Technology) and ILMN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NAUT is a small-cap quality compounder stock; CDNA is a small-cap quality compounder stock; SEER is a small-cap quality compounder stock; QBTS is a small-cap high-growth stock; ILMN is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.